Quality of Recovery After Hip Fracture Surgery: US-guided PENG Block Versus FICB

Not Applicable

Completed

• Conditions: Enhanced Recovery After Surgery

• Registration Number: NCT05968014
• Lead Sponsor: University Tunis El Manar

Brief Summary

Patients were randomly divided into two groups to receive either ultrasound-guided pericapsular nerve group block (PENG group) or fascia iliaca compartment block (FICB group), using 20 ml of 0.2% ropivacaine

Detailed Description

Participants were randomly divided into two groups : group PENG and group FICB, to receive either ultrasound-guided pericapsular nerve group block or fascia iliaca compartment block, using 50 ml of 0.2% ropivacaine.

For the FICB, a linear ultrasound probe was placed in the transverse plane and start scanning at the level of the inguinal crease to identify the femoral artery medially and the femoral nerve lateral to the femoral artery. The iliopsoas muscle should be seen overlying fascia iliaca. The block should be performed proximal to the arterial bifurcation. A 50 mm needle was introduced using an in-plane approach to penetrate the fascia iliaca. The hydro dissection separate the fascia iliaca from the iliac muscle, and a total volume of 20 ml of 0.2% ropivacaine was injected in this created space.

The PENG bloc is performed with a low frequency curvilinear ultrasound probe, which was initially placed in a transverse plane over the antero inferior iliac spine and the aligned with the pubic ramus by rotating the probe counterclockwise approximately 45 degrees. In this view, it is possible to observe the iliopubic eminence, the iliopsoas muscle tendon, the femoral artery and the pectineus muscle. A 100 mm needle was inserted from lateral to medial in an in-plane approach to place the tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly. Negative aspiration should be observed before injection of local anaesthetic and a total volume of 20 ml of 0.2% ropivacaine was injected.

Spinal anesthesia was performed after 20 minutes.

QoR-15 score was assessed before the intervention and 24 hours postoperatively.

Study Timeline

• Study Start: 2022-02-01
• Primary Completion: 2022-07-31
• Study Completion: 2022-07-31
• Status Verified: 2023-07
• Study First Submitted: 2023-07-11
• Study First Submitted QC: 2023-07-22
• Study First Posted: 2023-08-01
• Last Update Submitted: 2024-03-02
• Last Update Posted: 2024-03-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• patients aged above 65 years
• patients with an american society of anesthesiologists physical status I to III
• patients undergoing hip fracture surgical repair

Exclusion Criteria

• patients with an american society of anesthesiologists physical status IV or more
• inability or refusal to sign informed consent
• contraindications for regional nerve block or spinal anesthesia
• impaired cognition or dementia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
The Quality of Recovery-15 scores at 24 hours postoperatively.	before and 24 hours after surgery	Change in Quality of Recovery-15 (QoR-15) scores before and 24 hours after surgery.; The QoR-15 score consists of 15 items, and includes five dimensions: pain (two items), physical confort (five items), physical independance (two items), psychological support (two items) and emotional state (four items). Each item's score ranged from 0 to 10, and the total score ranged from 0 to 150, with a higher QoR-15 score indicating a better quality of recovery.

Secondary Outcome Measures

Name	Time	Method
The strength of the quadriceps	24 hours after surgery	The strength of the quadriceps muscle was measured 24 hours after surgery. It was determined by testing the movement of the knee and the hip.
Visual analogue scale	24 hours after surgery	change in visual analogue scale ((VAS) with 0 indicating no pain and 10 indicating the worst imaginable pain) at rest and on movement on postoperative day 1.

Trial Locations

Locations (1)

Nabeul hospital, Mohamed Taher Maamouri; 🇹🇳 Nabeul, Mrezga, Tunisia